NT

Nissim Torabi-Pour

Chief Technical Officer

SiSaf Ltd

Guildford, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
SiSaf Ltd
Industry
research
Employees
21.0
Seniority
C suite
Annual Revenue
4000000.0
Total Funding
21798545.0
Latest Funding
Series B

Technologies

Outlook Nginx Mobile Friendly Quantcast Gauges Google Font API Google Tag Manager WordPress.org Remote

Keywords

drug delivery drug development gene therapy drug reformulation corneal dystrophy osteopetrosis keloid scars biotechnology research rna delivery bio-courier technology silicon nanoparticles rare genetic disorders osteopetrosis treatment sirna therapeutics achondroplasia treatment pancreatic cancer therapy non-viral delivery systems lipid nanoparticles biopharmaceutical development rna therapeutics on-demand rna preparation biodegradable carriers cell targeting therapeutic gene editing biocompatible technology hybrid drug delivery personalized medicine clinical trial therapeutic innovation disease-modifying therapies manufacturing scalability gene silencing topical drug formulation genetic bone diseases crispr-cas9 technology fda orphan drug designation sirna programming disease management biological therapies oklahoma genetic disorders delivering rna therapeutics rna interference clinical research biological product development sustainable biomedicine cross-species rna delivery molecular targeting next-generation therapeutics biological stabilization biostatistics in drug development partnership in drug formulation therapeutics for pediatric disorders

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans